CVac
id:
cvac-241-11552296
title:
CVac
text:
CVac, is an immunotherapeutic agent that was 1st developed in Australia. CVac was developed by the biotechnology company Prima BioMed through to Phase II clinical studies between 2001 and 2015. After inconclusive clinical data in ovarian cancer 2013 and 2014, Prima announced in February 2015 that it had ceased recruiting into CVAc clinical studies and was seeking commercial partners for the product.
brand slug:
wiki
category slug:
encyclopedia
description:
Immunotherapeutic agent that was 1st developed in Australia
original url:
https://en.wikipedia.org/wiki/CVac
date created:
date modified:
2023-11-07T07:02:59Z
main entity:
{"identifier":"Q22907609","url":"https://www.wikidata.org/entity/Q22907609"}
image:
fields total:
13
integrity:
14